- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/6 | 0.74 | 1.48 | 0.95 | 4.16 | 0.61 | 2.11 | N/A | - | ||
| 2026/5 | 0.73 | 16.0 | 1.04 | 3.42 | 0.53 | 2.11 | N/A | - | ||
| 2026/4 | 0.63 | -15.49 | 0.12 | 2.69 | 0.39 | 1.93 | N/A | - | ||
| 2026/3 | 0.75 | 35.8 | 0.79 | 2.05 | 0.48 | 2.05 | 0.48 | - | ||
| 2026/2 | 0.55 | -26.92 | 0.07 | 1.3 | 0.3 | 2.25 | 0.44 | - | ||
| 2026/1 | 0.75 | -19.97 | 0.47 | 0.75 | 0.47 | 2.5 | 0.4 | - | ||
| 2025/12 | 0.94 | 17.52 | 1.19 | 8.87 | 0.37 | 2.51 | 0.33 | - | ||
| 2025/11 | 0.8 | 4.09 | -1.66 | 7.92 | 0.27 | 2.18 | 0.38 | - | ||
| 2025/10 | 0.77 | 27.63 | -4.42 | 7.12 | 0.5 | 2.23 | 0.37 | - | ||
| 2025/9 | 0.6 | -29.74 | 0.02 | 6.35 | 1.13 | 2.21 | 0.37 | - | ||
| 2025/8 | 0.86 | 14.23 | 0.02 | 5.75 | 1.25 | 2.35 | 0.35 | - | ||
| 2025/7 | 0.75 | 1.96 | -1.08 | 4.89 | 1.47 | 2.22 | 0.37 | - | ||
| 2025/6 | 0.74 | 1.57 | -2.47 | 4.14 | 1.94 | 2.09 | 0.35 | - | ||
| 2025/5 | 0.73 | 14.94 | -0.85 | 3.4 | 2.96 | 2.1 | 0.35 | - | ||
| 2025/4 | 0.63 | -14.92 | 2.32 | 2.67 | 4.05 | 1.92 | 0.38 | - | ||
| 2025/3 | 0.74 | 34.82 | 5.2 | 2.04 | 4.59 | 2.04 | 0.35 | - | ||
| 2025/2 | 0.55 | -26.62 | 8.96 | 1.3 | 4.25 | 2.23 | 0.32 | - | ||
| 2025/1 | 0.75 | -19.4 | 1.04 | 0.75 | 1.04 | 2.5 | 0.29 | - | ||
| 2024/12 | 0.93 | 14.2 | 14.7 | 8.83 | 23.88 | 2.55 | 0.28 | - | ||
| 2024/11 | 0.82 | 1.17 | 31.37 | 7.9 | 25.06 | 2.22 | 0.32 | - | ||
| 2024/10 | 0.81 | 33.57 | 34.22 | 7.09 | 24.38 | 2.27 | 0.32 | - | ||
| 2024/9 | 0.6 | -29.74 | 6.41 | 6.28 | 23.22 | 2.22 | 0.35 | - | ||
| 2024/8 | 0.86 | 12.96 | 6.66 | 5.68 | 25.32 | 2.37 | 0.32 | - | ||
| 2024/7 | 0.76 | 0.53 | 10.3 | 4.82 | 29.35 | 2.25 | 0.34 | - | ||
| 2024/6 | 0.76 | 3.26 | 6.19 | 4.06 | 33.68 | 2.11 | 0.39 | - | ||
| 2024/5 | 0.73 | 18.62 | 17.98 | 3.3 | 42.09 | 2.06 | 0.4 | - | ||
| 2024/4 | 0.62 | -12.52 | 23.42 | 2.57 | 50.87 | 1.83 | 0.45 | 可吸收防沾黏凝膠及關節腔注射劑業務銷售增加。 | ||
| 2024/3 | 0.71 | 39.64 | 16.84 | 1.95 | 62.28 | 1.95 | N/A | 可吸收防沾黏凝膠及關節腔注射劑業務銷售增加。 | ||
| 2024/2 | 0.51 | -31.96 | 108.2 | 1.25 | 108.01 | 2.06 | N/A | 可吸收防沾黏凝膠及關節腔注射劑業務銷售增加 | ||
| 2024/1 | 0.74 | -8.5 | 107.89 | 0.74 | 107.89 | 2.17 | N/A | 可吸收防沾黏凝膠、關節腔注射劑及膀胱灌注液業務銷售增加。 | ||
| 2023/12 | 0.81 | 30.79 | 25.55 | 7.13 | 27.92 | 2.03 | N/A | - | ||
| 2023/11 | 0.62 | 3.37 | 40.47 | 6.32 | 28.23 | 1.79 | N/A | - | ||
| 2023/10 | 0.6 | 5.89 | 17.59 | 5.7 | 27.03 | 1.97 | N/A | - | ||
| 2023/9 | 0.57 | -29.58 | -16.15 | 5.1 | 28.24 | 2.06 | N/A | - | ||
| 2023/8 | 0.81 | 16.81 | 107.79 | 4.53 | 37.34 | 2.21 | N/A | 可吸收防沾黏凝膠、關節腔注射劑及皮下填補劑業務銷售增加。 | ||
| 2023/7 | 0.69 | -3.21 | 17.69 | 3.73 | 27.96 | 2.02 | N/A | - | ||
| 2023/6 | 0.71 | 14.72 | 25.73 | 3.04 | 30.55 | 1.83 | N/A | - | ||
| 2023/5 | 0.62 | 24.09 | 42.17 | 2.32 | 32.1 | 1.72 | N/A | - | ||
| 2023/4 | 0.5 | -17.18 | 56.58 | 1.7 | 28.78 | 1.35 | N/A | 可吸收防沾黏凝膠及關節腔注射劑業務銷售增加。 | ||
| 2023/3 | 0.6 | 148.82 | 5.97 | 1.2 | 19.93 | 1.2 | N/A | - | ||
| 2023/2 | 0.24 | -32.06 | 3.96 | 0.6 | 38.26 | 1.25 | N/A | - | ||
| 2023/1 | 0.36 | -44.74 | 78.21 | 0.36 | 78.21 | 1.45 | N/A | 皮下填補劑業務銷售增加。 | ||
| 2022/12 | 0.65 | 46.34 | -5.29 | 5.57 | 10.24 | 1.6 | N/A | - | ||
| 2022/11 | 0.44 | -13.46 | 16.81 | 4.93 | 12.67 | 1.63 | N/A | - | ||
| 2022/10 | 0.51 | -24.49 | 49.43 | 4.49 | 12.28 | 1.57 | N/A | - | ||
| 2022/9 | 0.68 | 74.52 | 64.52 | 3.97 | 8.8 | 1.65 | N/A | 關節腔注射劑及可吸收防沾黏凝膠業務銷售增加。 | ||
| 2022/8 | 0.39 | -33.83 | -29.74 | 3.3 | 1.74 | 1.54 | N/A | - | ||
| 2022/7 | 0.59 | 3.4 | 88.67 | 2.91 | 8.19 | 1.59 | N/A | 可吸收防沾黏凝膠、皮下填補劑及關節腔注射劑業務銷售增加。 | ||
| 2022/6 | 0.57 | 29.72 | 4.93 | 2.33 | -2.29 | 1.32 | N/A | - | ||
| 2022/5 | 0.44 | 36.66 | 2.89 | 1.76 | -4.41 | 1.33 | N/A | - | ||
| 2022/4 | 0.32 | -43.94 | 4.97 | 1.32 | -6.59 | 1.12 | N/A | - | ||
| 2022/3 | 0.57 | 144.1 | -1.2 | 1.0 | -9.76 | 1.0 | N/A | - | ||
| 2022/2 | 0.23 | 16.45 | 2.66 | 0.43 | -18.98 | 1.12 | N/A | - | ||
| 2022/1 | 0.2 | -70.63 | -34.96 | 0.2 | -34.96 | 1.26 | N/A | - | ||
| 2021/12 | 0.68 | 80.5 | 35.29 | 5.06 | 8.28 | 1.4 | N/A | - | ||
| 2021/11 | 0.38 | 10.7 | 24.02 | 4.37 | 5.0 | 1.13 | N/A | - | ||
| 2021/10 | 0.34 | -16.87 | -32.99 | 3.99 | 3.5 | 1.3 | N/A | - | ||
| 2021/9 | 0.41 | -25.47 | 72.3 | 3.65 | 9.06 | 1.27 | N/A | 關節腔注射劑及可吸收防沾黏業務銷售增加。 | ||
| 2021/8 | 0.55 | 77.67 | -21.44 | 3.24 | 4.21 | 0.0 | N/A | - | ||
| 2021/7 | 0.31 | -42.48 | 15.29 | 2.69 | 11.68 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2026/1 | 0.75 | 2025/1 | 0.75 | 2024/1 | 0.74 | 2023/1 | 0.36 | 2022/1 | 0.2 |
| 2026/2 | 0.55 | 2025/2 | 0.55 | 2024/2 | 0.51 | 2023/2 | 0.24 | 2022/2 | 0.23 |
| 2026/3 | 0.75 | 2025/3 | 0.74 | 2024/3 | 0.71 | 2023/3 | 0.6 | 2022/3 | 0.57 |
| 2026/4 | 0.63 | 2025/4 | 0.63 | 2024/4 | 0.62 | 2023/4 | 0.5 | 2022/4 | 0.32 |
| 2026/5 | 0.73 | 2025/5 | 0.73 | 2024/5 | 0.73 | 2023/5 | 0.62 | 2022/5 | 0.44 |
| 2026/6 | 0.74 | 2025/6 | 0.74 | 2024/6 | 0.76 | 2023/6 | 0.71 | 2022/6 | 0.57 |
| N/A | N/A | 2025/7 | 0.75 | 2024/7 | 0.76 | 2023/7 | 0.69 | 2022/7 | 0.59 |
| N/A | N/A | 2025/8 | 0.86 | 2024/8 | 0.86 | 2023/8 | 0.81 | 2022/8 | 0.39 |
| N/A | N/A | 2025/9 | 0.6 | 2024/9 | 0.6 | 2023/9 | 0.57 | 2022/9 | 0.68 |
| N/A | N/A | 2025/10 | 0.77 | 2024/10 | 0.81 | 2023/10 | 0.6 | 2022/10 | 0.51 |
| N/A | N/A | 2025/11 | 0.8 | 2024/11 | 0.82 | 2023/11 | 0.62 | 2022/11 | 0.44 |
| N/A | N/A | 2025/12 | 0.94 | 2024/12 | 0.93 | 2023/12 | 0.81 | 2022/12 | 0.65 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 26Q1 (8) | 0.02 | 0.0 | -66.67 |
| 25Q4 (7) | 0.02 | 100.0 | -33.33 |
| 25Q3 (6) | 0.01 | -85.71 | -83.33 |
| 25Q2 (5) | 0.07 | 16.67 | -63.16 |
| 25Q1 (4) | 0.06 | 100.0 | 0.0 |
| 24Q4 (3) | 0.03 | -50.0 | 0.0 |
| 24Q3 (2) | 0.06 | -68.42 | 0.0 |
| 24Q2 (1) | 0.19 | 0.0 | 0.0 |